UNITED CAPITAL FINANCIAL ADVISORS, LLC - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 24 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UNITED CAPITAL FINANCIAL ADVISORS, LLC ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q1 2022$46,000
-39.5%
16,2460.0%0.00%
Q4 2021$76,000
+72.7%
16,2460.0%0.00%
Q3 2021$44,000
-4.3%
16,2460.0%0.00%
Q2 2021$46,000
-6.1%
16,2460.0%0.00%
Q1 2021$49,000
+2.1%
16,2460.0%0.00%
Q4 2020$48,000
-7.7%
16,2460.0%0.00%
Q3 2020$52,000
-3.7%
16,2460.0%0.00%
Q2 2020$54,000
-8.5%
16,2460.0%0.00%
Q1 2020$59,000
-29.8%
16,2460.0%0.00%
-100.0%
Q4 2019$84,000
-12.5%
16,2460.0%0.00%0.0%
Q3 2019$96,000
-10.3%
16,246
-3.4%
0.00%0.0%
Q2 2019$107,000
+11.5%
16,812
+1.3%
0.00%0.0%
Q1 2019$96,000
-8.6%
16,604
-0.1%
0.00%0.0%
Q4 2018$105,000
+10.5%
16,6260.0%0.00%0.0%
Q3 2018$95,000
-6.9%
16,6260.0%0.00%0.0%
Q2 2018$102,000
-8.1%
16,6260.0%0.00%0.0%
Q1 2018$111,000
-9.8%
16,6260.0%0.00%0.0%
Q4 2017$123,000
-52.5%
16,626
-54.6%
0.00%
-50.0%
Q3 2017$259,0000.0%36,6260.0%0.00%0.0%
Q2 2017$259,000
+2.0%
36,6260.0%0.00%0.0%
Q1 2017$254,000
+26.4%
36,6260.0%0.00%0.0%
Q4 2016$201,000
-36.6%
36,626
-42.1%
0.00%
-33.3%
Q3 2016$317,000
-12.9%
63,305
-13.1%
0.00%
-25.0%
Q2 2016$364,000
+12.0%
72,826
+0.5%
0.00%0.0%
Q1 2016$325,000
-14.7%
72,4460.0%0.00%0.0%
Q4 2015$381,000
-8.9%
72,4460.0%0.00%
-20.0%
Q3 2015$418,000
-19.3%
72,4460.0%0.01%
-16.7%
Q2 2015$518,000
+9.1%
72,4460.0%0.01%0.0%
Q1 2015$475,000
-45.2%
72,446
-50.0%
0.01%
-14.3%
Q4 2014$866,000
+12.8%
144,892
-6.8%
0.01%
-46.2%
Q3 2014$768,000
-13.6%
155,402
-21.4%
0.01%
-18.8%
Q2 2014$889,0000.0%197,6460.0%0.02%
-15.8%
Q1 2014$889,000
-12.0%
197,6460.0%0.02%
-44.1%
Q4 2013$1,010,000
-47.1%
197,646
-53.1%
0.03%
-44.3%
Q3 2013$1,910,000
-14.9%
421,550
-4.1%
0.06%
+1.7%
Q2 2013$2,245,000439,3640.06%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q3 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 896,170$4,615,0003.22%
Ariel Investments 1,010,220$5,203,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 183,000$942,0000.01%
Anfield Capital Management, LLC 4,530$23,0000.01%
Financial Gravity Asset Management, Inc. 2,000$10,0000.01%
Oakworth Capital, Inc. 3,052$16,0000.00%
BAILARD, INC. 11,816$61,0000.00%
DIMENSIONAL FUND ADVISORS LP 860,319$4,431,0000.00%
Renaissance Technologies 469,338$2,417,0000.00%
ACADIAN ASSET MANAGEMENT LLC 98,192$506,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders